NCT00000125View on ClinicalTrials.gov

Ocular Hypertension Treatment Study (OHTS)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,636

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2019

Conditions
Ocular HypertensionGlaucoma
Interventions
DRUG

Topical ocular hypotensive eye drops.

Topical ocular hypotensive eye drops.

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Washington University School of Medicine

OTHER